Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08QEF
|
|||
| Former ID |
DIB002713
|
|||
| Drug Name |
CEP-37250
|
|||
| Synonyms |
ART-104; KHK-2804; SC-104, Arana; SC-104, Peptech; SC-104, Scancell; Anti-tumor-associated glycoprotein/glucolipid epitope monoclonal antibody (cancer), Scancell
Click to Show/Hide
|
|||
| Indication | Advanced solid tumour [ICD-11: 2A00-2F9Z; ICD-9: 140-199] | Phase 1 | [1] | |
| Company |
Kyowa hakko kirin pharma; teva pharmaceutical
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01447732) Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.